PD-0499 Bonesparing radiotherapy for anal cancer. -Initial planning quality for the DACG II trial. (May 2022) - Kronborg, C.; Nyvang, L.; Hansen, J.; Serup-Hansen, E.; Havelund, B.; Wilken, E.; Mc Ilroy, S.P.; Spindler, K.G.